Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma

Details 詳細情報について

• CRID

  1360574093746337664

• DOI

  10.1007/s00277-011-1287-z

• ISSN

  14320584

  09395555

• Web Site

  http://link.springer.com/content/pdf/10.1007/s00277-011-1287-z.pdf

  http://link.springer.com/article/10.1007/s00277-011-1287-z/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s00277-011-1287-z

• Data Source

  • Crossref